UA28103U - Комплексный противобактериальный сорбционный препарат сертасил с некролитическим действием для лечения гнойных ран, трофических язв и ожогов - Google Patents
Комплексный противобактериальный сорбционный препарат сертасил с некролитическим действием для лечения гнойных ран, трофических язв и ожогов Download PDFInfo
- Publication number
- UA28103U UA28103U UAU200707897U UAU200707897U UA28103U UA 28103 U UA28103 U UA 28103U UA U200707897 U UAU200707897 U UA U200707897U UA U200707897 U UAU200707897 U UA U200707897U UA 28103 U UA28103 U UA 28103U
- Authority
- UA
- Ukraine
- Prior art keywords
- wounds
- drug
- aerosil
- effect
- trophic ulcers
- Prior art date
Links
- 206010052428 Wound Diseases 0.000 title claims abstract description 27
- 208000027418 Wounds and injury Diseases 0.000 title claims abstract description 27
- 239000000203 mixture Substances 0.000 title claims abstract description 12
- 208000025865 Ulcer Diseases 0.000 title claims abstract description 9
- 231100000397 ulcer Toxicity 0.000 title claims abstract description 9
- 230000001228 trophic effect Effects 0.000 title claims abstract description 8
- 238000001179 sorption measurement Methods 0.000 title claims abstract description 5
- 230000003282 necrolytic effect Effects 0.000 title claims abstract description 4
- 230000000844 anti-bacterial effect Effects 0.000 title abstract description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229940079593 drug Drugs 0.000 claims abstract description 13
- 239000003814 drug Substances 0.000 claims abstract description 13
- 229910002012 Aerosil® Inorganic materials 0.000 claims abstract description 9
- 230000001338 necrotic effect Effects 0.000 claims abstract description 9
- 239000000377 silicon dioxide Substances 0.000 claims abstract 4
- 239000002594 sorbent Substances 0.000 claims abstract 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 230000000845 anti-microbial effect Effects 0.000 claims description 2
- 238000012876 topography Methods 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 description 9
- 206010028851 Necrosis Diseases 0.000 description 5
- 230000017074 necrotic cell death Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 229940000634 serratiopeptidase Drugs 0.000 description 4
- 108010038132 serratiopeptidase Proteins 0.000 description 4
- 229910021485 fumed silica Inorganic materials 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000013543 active substance Substances 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 230000000141 anti-hypoxic effect Effects 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- XBCXJKGHPABGSD-UHFFFAOYSA-N methyluracil Natural products CN1C=CC(=O)NC1=O XBCXJKGHPABGSD-UHFFFAOYSA-N 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- OUFRIWNNMFWZTM-UHFFFAOYSA-M sodium arsanilate Chemical group [Na+].NC1=CC=C([As](O)([O-])=O)C=C1 OUFRIWNNMFWZTM-UHFFFAOYSA-M 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 238000011477 surgical intervention Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010006797 Burns first degree Diseases 0.000 description 1
- 206010006803 Burns third degree Diseases 0.000 description 1
- 206010061043 Clostridial infection Diseases 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 206010062255 Soft tissue infection Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 210000003815 abdominal wall Anatomy 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004964 aerogel Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 230000003501 anti-edematous effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- VAAUVRVFOQPIGI-SPQHTLEESA-N ceftriaxone Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NC(=O)C(=O)NN1C VAAUVRVFOQPIGI-SPQHTLEESA-N 0.000 description 1
- 229960004755 ceftriaxone Drugs 0.000 description 1
- 201000002816 chronic venous insufficiency Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229960001193 diclofenac sodium Drugs 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- -1 polymethylsiloxane Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000005067 remediation Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- JGMJQSFLQWGYMQ-UHFFFAOYSA-M sodium;2,6-dichloro-n-phenylaniline;acetate Chemical compound [Na+].CC([O-])=O.ClC1=CC=CC(Cl)=C1NC1=CC=CC=C1 JGMJQSFLQWGYMQ-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- FXSGDOZPBLGOIN-UHFFFAOYSA-N trihydroxy(methoxy)silane Chemical compound CO[Si](O)(O)O FXSGDOZPBLGOIN-UHFFFAOYSA-N 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 201000002282 venous insufficiency Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/38—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0095—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A61L2300/254—Enzymes, proenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/2404—Serralysin (3.4.24.40)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Composite Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Комплексный противобактериальный сорбционный препарат с некролитическим действием для лечения гнойных ран, трофических язв и ожогов, инфильтратов с выраженным некротическим и экссудативным компонентами представляет собой кремнеземный сорбент с иммобилизованным на нем лекарственным средством. В качестве кремнеземного сорбент препарат содержит аэросил, а в качестве лекарственного средства – сератиопептидазу.
Priority Applications (27)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU200707897U UA28103U (ru) | 2007-07-12 | 2007-07-12 | Комплексный противобактериальный сорбционный препарат сертасил с некролитическим действием для лечения гнойных ран, трофических язв и ожогов |
| ES08779534T ES2353683T3 (es) | 2007-07-12 | 2008-07-11 | Composición antimicrobiana. |
| BRPI0814549-0A BRPI0814549B1 (pt) | 2007-07-12 | 2008-07-11 | Composição antimicrobiana |
| AT08779534T ATE488255T1 (de) | 2007-07-12 | 2008-07-11 | Antimikrobielle zusammensetzung |
| DE602008003584T DE602008003584D1 (de) | 2007-07-12 | 2008-07-11 | Antimikrobielle zusammensetzung |
| AU2008275852A AU2008275852B2 (en) | 2007-07-12 | 2008-07-11 | Antimicrobial composition |
| EP10191280A EP2277559A1 (en) | 2007-07-12 | 2008-07-11 | Antimicrobial composition |
| EA201070130A EA016764B1 (ru) | 2007-07-12 | 2008-07-11 | Противомикробная композиция |
| MYPI2010000038A MY148077A (en) | 2007-07-12 | 2008-07-11 | Antimicrobial composition |
| EP08779534A EP2170415B1 (en) | 2007-07-12 | 2008-07-11 | Antimicrobial composition |
| CA2693087A CA2693087C (en) | 2007-07-12 | 2008-07-11 | Antimicrobial composition |
| PCT/UA2008/000041 WO2009008851A2 (en) | 2007-07-12 | 2008-07-11 | Antimicrobial composition |
| MX2010000367A MX2010000367A (es) | 2007-07-12 | 2008-07-11 | Composicion antimicrobiana. |
| KR1020107003161A KR101482960B1 (ko) | 2007-07-12 | 2008-07-11 | 항균 조성물 |
| CN200880024342XA CN101772356B (zh) | 2007-07-12 | 2008-07-11 | 抗菌组合物 |
| SI200830123T SI2170415T1 (sl) | 2007-07-12 | 2008-07-11 | Antimikrobni sestavek |
| JP2010516012A JP5464750B2 (ja) | 2007-07-12 | 2008-07-11 | 抗菌性組成物 |
| PL08779534T PL2170415T3 (pl) | 2007-07-12 | 2008-07-11 | Kompozycja przeciwbakteryjna |
| US12/668,827 US9302027B2 (en) | 2007-07-12 | 2008-07-11 | Antimicrobial composition comprising pyrogenic silica and serratiopeptidase |
| DK08779534.0T DK2170415T3 (da) | 2007-07-12 | 2008-07-11 | Antimikrobielt præparat |
| PT08779534T PT2170415E (pt) | 2007-07-12 | 2008-07-11 | Composição antimicrobiana |
| ZA2010/00126A ZA201000126B (en) | 2007-07-12 | 2010-01-07 | Antimicrobial composition |
| CY20111100153T CY1111652T1 (el) | 2007-07-12 | 2011-02-09 | Αντιμικροβiακη συνθεση |
| HR20110107T HRP20110107T1 (hr) | 2007-07-12 | 2011-02-15 | Antimikrobni sastav |
| US14/753,641 US9757436B2 (en) | 2007-07-12 | 2015-06-29 | Antimicrobial composition comprising pyrogenic silica and serrathiopeptidase and uses thereof |
| US15/086,724 US20160206709A1 (en) | 2007-07-12 | 2016-03-31 | Antimicrobial composition comprising pyrogenic silica and serrathopeptidase and uses thereof |
| US15/681,407 US10166275B2 (en) | 2007-07-12 | 2017-08-20 | Antimicrobial composition comprising pyrogenic silica and serrathiopeptidase and uses thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU200707897U UA28103U (ru) | 2007-07-12 | 2007-07-12 | Комплексный противобактериальный сорбционный препарат сертасил с некролитическим действием для лечения гнойных ран, трофических язв и ожогов |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA28103U true UA28103U (ru) | 2007-11-26 |
Family
ID=55588706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU200707897U UA28103U (ru) | 2007-07-12 | 2007-07-12 | Комплексный противобактериальный сорбционный препарат сертасил с некролитическим действием для лечения гнойных ран, трофических язв и ожогов |
Country Status (23)
| Country | Link |
|---|---|
| US (4) | US9302027B2 (ru) |
| EP (2) | EP2170415B1 (ru) |
| JP (1) | JP5464750B2 (ru) |
| KR (1) | KR101482960B1 (ru) |
| CN (1) | CN101772356B (ru) |
| AT (1) | ATE488255T1 (ru) |
| AU (1) | AU2008275852B2 (ru) |
| BR (1) | BRPI0814549B1 (ru) |
| CA (1) | CA2693087C (ru) |
| CY (1) | CY1111652T1 (ru) |
| DE (1) | DE602008003584D1 (ru) |
| DK (1) | DK2170415T3 (ru) |
| EA (1) | EA016764B1 (ru) |
| ES (1) | ES2353683T3 (ru) |
| HR (1) | HRP20110107T1 (ru) |
| MX (1) | MX2010000367A (ru) |
| MY (1) | MY148077A (ru) |
| PL (1) | PL2170415T3 (ru) |
| PT (1) | PT2170415E (ru) |
| SI (1) | SI2170415T1 (ru) |
| UA (1) | UA28103U (ru) |
| WO (1) | WO2009008851A2 (ru) |
| ZA (1) | ZA201000126B (ru) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010079209A3 (en) * | 2009-01-08 | 2010-09-02 | Golub Alexandr A | Compositions for treating wounds and skin conditions |
| MD4197C1 (ru) * | 2012-10-22 | 2013-09-30 | Мария ДАНУ | Метод лечения трофических язв |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102961336B (zh) * | 2012-12-13 | 2014-08-13 | 清华大学深圳研究生院 | 纳米级铂类药物及其制备方法 |
| BR112016010351A2 (pt) | 2013-11-06 | 2017-08-08 | Invenres Gmbh | Composições em forma de pó, métodos de produção de uma composição em forma de pó, preparação farmacêutica, e artigo médico |
| WO2016071405A2 (en) * | 2014-11-04 | 2016-05-12 | Invenres Gmbh | Pharmaceutical preparation and method of its production and use |
| CN106558599B (zh) * | 2015-09-29 | 2020-04-07 | 中芯国际集成电路制造(上海)有限公司 | 电阻随机存取存储器及其形成方法 |
| CN108309941B (zh) * | 2018-03-20 | 2023-08-11 | 南京工业大学 | 一种舍雷肽酶外用粉剂及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3792160A (en) * | 1972-01-18 | 1974-02-12 | Takeda Chemical Industries Ltd | Method of treating inflammation and composition therefor |
| JPS5826822A (ja) * | 1981-08-10 | 1983-02-17 | Kaken Pharmaceut Co Ltd | 慢性腎炎治療剤 |
| WO2003009877A1 (en) * | 2001-07-24 | 2003-02-06 | Advanced Biotechnologies International | Topical pharmaceutical formulation |
-
2007
- 2007-07-12 UA UAU200707897U patent/UA28103U/ru unknown
-
2008
- 2008-07-11 DK DK08779534.0T patent/DK2170415T3/da active
- 2008-07-11 MY MYPI2010000038A patent/MY148077A/en unknown
- 2008-07-11 BR BRPI0814549-0A patent/BRPI0814549B1/pt not_active IP Right Cessation
- 2008-07-11 ES ES08779534T patent/ES2353683T3/es active Active
- 2008-07-11 SI SI200830123T patent/SI2170415T1/sl unknown
- 2008-07-11 EP EP08779534A patent/EP2170415B1/en active Active
- 2008-07-11 CA CA2693087A patent/CA2693087C/en active Active
- 2008-07-11 KR KR1020107003161A patent/KR101482960B1/ko active IP Right Grant
- 2008-07-11 PT PT08779534T patent/PT2170415E/pt unknown
- 2008-07-11 AU AU2008275852A patent/AU2008275852B2/en not_active Ceased
- 2008-07-11 PL PL08779534T patent/PL2170415T3/pl unknown
- 2008-07-11 EP EP10191280A patent/EP2277559A1/en not_active Withdrawn
- 2008-07-11 WO PCT/UA2008/000041 patent/WO2009008851A2/en active Application Filing
- 2008-07-11 DE DE602008003584T patent/DE602008003584D1/de active Active
- 2008-07-11 JP JP2010516012A patent/JP5464750B2/ja not_active Expired - Fee Related
- 2008-07-11 MX MX2010000367A patent/MX2010000367A/es active IP Right Grant
- 2008-07-11 US US12/668,827 patent/US9302027B2/en not_active Expired - Fee Related
- 2008-07-11 CN CN200880024342XA patent/CN101772356B/zh active Active
- 2008-07-11 AT AT08779534T patent/ATE488255T1/de active
- 2008-07-11 EA EA201070130A patent/EA016764B1/ru not_active IP Right Cessation
-
2010
- 2010-01-07 ZA ZA2010/00126A patent/ZA201000126B/en unknown
-
2011
- 2011-02-09 CY CY20111100153T patent/CY1111652T1/el unknown
- 2011-02-15 HR HR20110107T patent/HRP20110107T1/hr unknown
-
2015
- 2015-06-29 US US14/753,641 patent/US9757436B2/en active Active
-
2016
- 2016-03-31 US US15/086,724 patent/US20160206709A1/en not_active Abandoned
-
2017
- 2017-08-20 US US15/681,407 patent/US10166275B2/en active Active
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010079209A3 (en) * | 2009-01-08 | 2010-09-02 | Golub Alexandr A | Compositions for treating wounds and skin conditions |
| MD4197C1 (ru) * | 2012-10-22 | 2013-09-30 | Мария ДАНУ | Метод лечения трофических язв |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10166275B2 (en) | Antimicrobial composition comprising pyrogenic silica and serrathiopeptidase and uses thereof | |
| ES2554259T3 (es) | Apósito para heridas con capa permeable al aire | |
| RU2438654C1 (ru) | Гидрогелевая композиция для лечения ожогов | |
| CN1850291A (zh) | 具有促进伤口愈合、抗菌功能的液体伤口敷料 | |
| Udwadia | Ghee and honey dressing for infected wounds | |
| RU2471477C1 (ru) | Композиция комплекса сукцината хитозана и диоксидина с хлоргексидином, обладающая антибактериальным и ранозаживляющим эффектом | |
| CN101856322B (zh) | 一种磺胺嘧啶银控释凝胶及制备方法 | |
| Inoue et al. | The wound/burn guidelines–1: Wounds in general | |
| Sarheed et al. | Honey products and their potential in wound healing | |
| Swaim et al. | Management of small animal distal limb injuries | |
| UA28514U (ru) | Антисептический перевязочный материал | |
| RU2185149C1 (ru) | Ранозаживляющее средство "витамустим-гель" (варианты), способ его приготовления и способ лечения им поврежденой кожи, ран, ожогов и трофических язв | |
| BR102015029357A2 (pt) | The use of bandages and membranes produced with quitosan and combined derivatives with various additives in the regeneration of injured fabrics and healing | |
| Біляєва | Comparative Clinical Study of the Wound Healing Effects of a Novel Micropore Particle Technology: Effects on Wounds, Venous Leg Ulcers, and Diabetic Foot Ulcers | |
| RU2195291C2 (ru) | Способ лечения гнойных ран | |
| Jones | Use of hydrogels and iodine in diabetic foot lesions | |
| UA64934A (en) | Complex antibacterial sorption preparation benegol for preventing anaerobic infection and treating purulent wounds, neurepathic eschar, and wounds and method for its manufacture | |
| WO2012108851A1 (ru) | Композиция для лечения гнойных ран | |
| UA75467C2 (en) | Remedy for treating wounds | |
| UA113250U (xx) | Комплексний антимікробний сорбційний препарат орнісератосил для профілактики аеробної і анаеробної інфекції та лікування гнійних ран, трофічних виразок, опіків | |
| UA65716A (en) | Complex antibacterial sorption composition "benegol forte" for preventing anaerobic infection and treating purulent wounds, neurepathic eschar, and burns, method for its manufacture and application | |
| CN104706661A (zh) | 复方蒙脱石聚维酮碘外用散剂及其制备方法和应用 | |
| UA75446C2 (en) | Composition for topical treatment of pyo-inflammatory processes in soft tissues |